Unknown

Dataset Information

0

Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial.


ABSTRACT:

Objective

To compare two subcutaneous insulin strategies for glycemic management of hyperglycemia in non-critically ill hospitalized patients with diabetes during enteral nutrition therapy (ENT).

Research design and methods

Fifty inpatients were prospectively randomized to receive sliding-scale regular insulin (SSRI) alone (n = 25) or in combination with insulin glargine (n = 25). NPH insulin was added for persistent hyperglycemia in the SSRI group (glucose >10 mmol/l).

Results

Glycemic control was similar in the SSRI and glargine groups (mean +/- SD study glucose 8.9 +/- 1.6 vs. 9.2 +/- 1.6 mmol/l, respectively; P = 0.71). NPH insulin was added in 48% of the SSRI group subjects. There were no group differences in frequency of hypoglycemia (1.3 +/- 4.1 vs. 1.1 +/- 1.8%; P = 0.35), total adverse events, or length of stay.

Conclusions

Both insulin strategies (SSRI with the addition of NPH for persistent hyperglycemia and glargine) demonstrated similar efficacy and safety in non-critically ill hospitalized patients with type 2 diabetes during ENT.

SUBMITTER: Korytkowski MT 

PROVIDER: S-EPMC2660455 | biostudies-literature | 2009 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial.

Korytkowski Mary T MT   Salata Rose J RJ   Koerbel Glory L GL   Selzer Faith F   Karslioglu Esra E   Idriss Almoatazbellah M AM   Lee Kenneth K W KK   Moser A James AJ   Toledo Frederico G S FG  

Diabetes care 20090401 4


<h4>Objective</h4>To compare two subcutaneous insulin strategies for glycemic management of hyperglycemia in non-critically ill hospitalized patients with diabetes during enteral nutrition therapy (ENT).<h4>Research design and methods</h4>Fifty inpatients were prospectively randomized to receive sliding-scale regular insulin (SSRI) alone (n = 25) or in combination with insulin glargine (n = 25). NPH insulin was added for persistent hyperglycemia in the SSRI group (glucose >10 mmol/l).<h4>Results  ...[more]

Similar Datasets

| S-EPMC2713651 | biostudies-literature
| S-EPMC3554296 | biostudies-literature
| S-EPMC6064602 | biostudies-literature
| S-EPMC5032960 | biostudies-literature
| S-EPMC11230797 | biostudies-literature
| S-EPMC5089951 | biostudies-literature
| S-EPMC6965526 | biostudies-literature
| S-EPMC7510023 | biostudies-literature
| S-EPMC6678336 | biostudies-literature
| S-EPMC3902568 | biostudies-literature